$0.9170
0.00890.98%
Last update: Nov 6, 10:11 AM
NovaBridge Biosciences
NBPNASDAQ
The average analyst price target for NovaBridge Biosciences is $9, 881.5% above the current price. The one analyst covering it rates it Buy. The latest change came on Feb 6, 2026, when HC Wainwright & Co. raised its price target on NovaBridge Biosciences from $7 to $9 and kept a Buy rating.
Price Target Range — 3 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
